Today's Healthcare Pulse
Hormone therapy slashes low bone density risk by 69%
A retrospective analysis shows menopausal hormone therapy cuts the risk of low bone mineral density by 69% among women. The finding was reported by Medical Xpress and echoed in a Healio piece.
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Transcript
Emergent BioSolutions reported a successful completion of its stabilization phase, cutting net debt by $156 million and improving leverage to 3.3x adjusted EBITDA. Adjusted EBITDA surged to $183 million, a $205 million swing from the prior year, while operating cash flow rose to $59 million. The company highlighted strong NARCAN nasal spray sales—22 million doses—and secured $550 million in medical countermeasure contracts. For 2025, Emergent projects revenue of $750‑$850 million with adjusted EBITDA between $150 million and $200 million, emphasizing margin expansion and continued growth in its core product lines.
Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Transcript
Ascendis (SNDX) reported €720 million total 2025 revenue, driven by €477 million from Yorvipath and €206 million from Skytrofa. Q4 operating profit hit €10 million and cash flow reached €73 million, leaving €616 million in cash at year‑end. Management guided 2026 operating cash flow of roughly...
Amphastar Pharmaceuticals Inc (AMPH) Q4 2025 Earnings Call Transcript
Amphastar Pharmaceuticals reported full‑year 2025 net revenues of $719.9 million, a modest 2% decline, while its flagship product Baqsimi grew 12% to $185.4 million. The company secured FDA approval for ipratropium bromide HFA (AMP‑007), gaining 180‑day generic exclusivity, and announced a major...
Pacira Biosciences Inc (PCRX) Q4 2025 Earnings Call Transcript
Pacira BioSciences reported a record $726 million in total 2025 revenue and an all‑time high non‑GAAP gross margin of 80%, driven by growth in its flagship product EXPAREL. EXPAREL sales rose 7% year‑over‑year to $155.8 million, though the increase was partially offset...
Alpha Teknova Inc (TKNO) Q4 2025 Earnings Call Transcript
Alpha Teknova reported Q4 2025 revenue of $10.5 million, a 9% year‑over‑year increase and the fifth consecutive quarter of growth, driven primarily by its Lab Essentials catalog line. Lab Essentials revenue rose 16% to $8.3 million, while Clinical Solutions revenue slipped 13%...
Privia Health Group Inc (PRVA) Q4 2025 Earnings Call Transcript
Privia Health reported a robust 2025, with implemented providers rising 12.3% to 5,380 and attributed lives increasing 22.7% to 1.54 million. Practice collections grew 16.9% to $3.47 billion and adjusted EBITDA surged 38.8% to $125.5 million, delivering a 130% free‑cash‑flow conversion. The company...
OPKO Health Inc (OPK) Q4 2025 Earnings Call Transcript
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Transcript
Anika Therapeutics reported total revenue of $27.8 million for the quarter, a 6% year‑over‑year decline driven primarily by lower pricing in its OEM osteoarthritis pain‑management channel. Commercial channel revenue rose 22% to $12 million, powered by a 25% surge in...
Personalis Inc (PSNL) Q4 2025 Earnings Call Transcript
Personalis reported a record $18.2 million Q4 2019 revenue, a 38% year‑over‑year increase, and full‑year revenue of $65.2 million, up 73% from 2018. The VA Million Veteran Program (MVP) remained the core revenue driver, contributing $43.5 million for the year and $13.8 million in...
Biodesix Inc (BDSX) Q4 2025 Earnings Call Transcript
Biodesix reported fourth‑quarter 2021 revenue of $7.2 million and total 2021 revenue of $54.5 million, a 20% year‑over‑year increase driven by strong growth in its core lung‑diagnostic portfolio. Core lung‑test sales jumped 49% to $18.7 million, while COVID‑19 testing revenue collapsed, lifting the...
Vericel Corp (VCEL) Q4 2025 Earnings Call Transcript
Vericel Corp. reported record third‑quarter revenue of $67.5 million, driven by a 25% jump in MACI sales to $55.7 million and a 21% rise in burn‑care revenue. Margin expansion outpaced top‑line growth, with adjusted EBITDA climbing 70% to $17 million and gross profit...
Alta Equipment Group Inc (ALTG) Q4 2025 Earnings Call Transcript
Align Technology reported a record $1.05 billion Q4 2025 revenue, up 5.3% year‑over‑year, driven by strong clear‑aligner sales and expanding Systems & Services. Non‑GAAP operating margin improved to 26.1%, the highest since 2021, while cash balances rose to $1.09 billion. The company...
Prospective Study in High-Risk Individuals Supports Primary Prevention Trials in MS
A prospective analysis of 1,903 first‑degree relatives of multiple sclerosis (MS) patients found an incidence of 211 cases per 100,000 per year—about 100‑fold higher than the general population—and a median conversion time of two years, with diagnosis typically at age...
Trump’s Atypical Surgeon General Pick Faces Senate Scrutiny: Key Takeaways
President Trump nominated Casey Means, a 38‑year‑old Stanford‑trained physician‑influencer, as surgeon general, but she has not completed her residency and holds an inactive medical license. During her HELP Committee hearing, senators pressed her on vaccine positions, past social‑media statements, and...
Medical Device Maker UFP Technologies Warns of Data Stolen in Cyberattack
UFP Technologies, a $600 million medical‑device maker, disclosed a cyberattack detected on February 14 that compromised several IT systems. The company isolated the breach, removed the threat and engaged external advisors, but confirmed that data was stolen and some functions, such as...
EHR Strategy Becomes a Recruitment Lever for Health Systems
Chief medical information officers are reframing EHR and AI investments from pure operational upgrades to strategic tools for clinician recruitment, retention, and burnout mitigation. Leaders at Sentara Health report over 75% adoption of AI‑generated discharge summaries, citing significant time savings...
CMS Announces Actions Addressing Fraud
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information on a prospective rule called Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), opening a 30‑day comment period after its Feb. 27 Federal Register publication. Simultaneously, CMS announced a...
Breaking: Trump Regime Cuts $260 Million in Medicaid Funds to Minnesota & Stops New Durable Medical Equipment Supplier Enrollment Nationally...
The Centers for Medicare & Medicaid Services (CMS) announced a $259.5 million deferral of federal Medicaid matching funds to Minnesota, citing questionable and potentially fraudulent claims. The agency also imposed a six‑month nationwide moratorium on new enrollment for Durable Medical Equipment,...
14 Health Systems Extend EHR Contracts with Altera Digital Health
Fourteen health systems have signed multiyear extensions for Altera Digital Health’s Sunrise electronic health record, reinforcing the vendor’s foothold in the acute‑care market. The renewed contracts cover institutions such as Phoenix Children’s, St. Mary’s, Grand Lake Health System and Hospital for...
Informed Refusal Vs. Denied Care: A Dental Case Study
A dentist refused to perform a routine cleaning without bitewing X‑rays, despite the patient’s low‑risk status and recent radiographs. The practice cited a two‑year imaging policy and warned that proceeding could jeopardize the hygienist’s license. After consulting the supervising dentist,...
Radiopharmaceutical Targeted Toward Treatment-Resistant Cancer Put on FDA's Fast Track
Aktis Oncology announced that its investigational radiopharmaceutical AKY-1189 has earned FDA Fast Track designation. The drug targets Nectin‑4, present in 80‑90 % of urothelial cancers, and delivers the alpha‑emitter actinium‑225 directly to tumors. AKY-1189 is in a Phase 1b trial covering urothelial,...
Health Systems Save Millions by Eliminating IT Applications
Health systems are realizing significant cost savings by consolidating their IT application portfolios. Emplify Health eliminated over 30 applications, cutting $3 million in direct costs and $1.3 million in soft savings, while Providence reduced its portfolio by more than a third, saving...
AHA Urges DOE to Broaden Proposed Update to Definition of ‘Professional Degree’
The American Hospital Association (AHA) submitted comments on the Department of Education’s proposed rule that redefines “graduate student” and “professional student” for federal loan eligibility. The rule limits the new definition of a professional degree to 11 fields, granting up...
An Endangered Natural Pharmacy Hidden in Coral: Hundreds of Reef-Dwelling Microbes Reveal Untapped Potential
A new Nature study led by ETH Zurich researchers sequenced the genomes of 645 bacteria and archaea from over 800 coral samples, revealing that more than 99% of these reef‑dwelling microbes were previously unknown. The analysis showed that each coral...
CAB+RPV LA Is Versatile, Preferred in Treatment-Naive Patients
Long‑acting cabotegravir/rilpivirine (CAB+RPV LA) demonstrated strong virologic control and high patient preference in both treatment‑naïve and treatment‑experienced cohorts presented at CROI 2026. In the VOLITION trial, 85% of ART‑naïve adults switched early from DTG/3TC to a q2‑month injectable, achieving 95% overall suppression...
Clalit Probes Suspected Cyberattack After Iranian-Linked Hackers Leak Patient Files
Clalit Health Services, Israel’s largest HMO, announced it is probing a suspected cyberattack after the Iranian‑linked group Handala claimed to have breached its systems. The hackers released thousands of documents containing patients' personal and medical information on public platforms. Clalit...
Study: Nearly 6 in 10 Women Projected to Have Cardiovascular Disease by 2050
A new American Heart Association study released Feb. 25 projects that 60% of U.S. women will develop cardiovascular disease by 2050. The analysis shows rising rates of heart disease, heart failure, atrial fibrillation and stroke, driven by higher prevalence of...
Feds Extend a Telehealth Rule that Could Help Save More People From Opioid Overdoses
The DEA and HHS have extended the pandemic‑era telehealth rule that lets providers prescribe buprenorphine for opioid use disorder without an in‑person visit, now allowing up to six months of remote treatment. Effective Jan. 1, the rule also eliminates record‑keeping requirements...
Hawaii District Court Upholds State 340B Contract Pharmacy Law
A Hawaii district court has upheld the state’s 340B contract‑pharmacy law, ruling that it is not preempted by federal regulations. The decision aligns with recent rulings in Minnesota and Louisiana that support state authority over 340B contract arrangements. The law...
Avoiding the 'Tech Talk Trap' In Healthcare, AI and Health IT Communications
Terry Rubin, co‑founder of The Professional Communicators, will address the “Tech Talk Trap” at HIMSS 2026, highlighting how jargon, information overload, and rapid delivery can alienate healthcare audiences. He explains that experts often lose message control when they prioritize technical...
PFO Closure After Thromboembolism Linked to Strong 20-Year Outcomes
A new 20‑year follow‑up of 130 patients who received transcatheter patent foramen ovale (PFO) closure after a paradoxical embolism shows sustained safety and efficacy. The cohort, with a mean age of 46, experienced a recurrent stroke rate of 0.04 per...
Iron Nanoparticle Eliminates Tuberculosis in Mice and May Pave the Way for New Treatments
Brazilian researchers have shown that an iron‑based compound, ferroin, encapsulated in lipid nanoparticles, completely eradicated Mycobacterium tuberculosis from mouse lungs after a 30‑day course. The formulation, LNP@FEP, stabilizes the drug, enhances the activity of existing antibiotics, and targets bacterial cell‑wall synthesis....
Zimmer Biomet Says Its SynTuition Algorithm Enhances Diagnostic Certainty
Zimmer Biomet announced that its machine‑learning tool SynTuition dramatically improves diagnostic certainty for periprosthetic joint infection (PJI). In a study of 274 real‑world cases, the algorithm matched expert diagnoses 96% of the time, outpacing a pooled physician group that achieved...
Soft-Robotic Glove Uses 37 Actuators to Cut Hand Swelling by up to 25%
Cornell researchers unveiled EdemaFlex, a soft‑robotic glove equipped with 37 shape‑memory‑alloy actuators that apply sequential pressure across all five fingers and the palm. In a small home‑use study of seven edema patients, a single 30‑minute session reduced hand volume by...
Housecall Providers to Affiliate With Chapters Health System
Oregon‑based Housecall Providers has signed a definitive agreement to affiliate with Chapters Health System, extending the nonprofit’s footprint in the Pacific Northwest. The transaction is slated to close in late spring or early summer 2026, subject to regulatory clearance. The...
Withdrawn | Non-Malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
The FDA has removed several accelerated approvals for non‑malignant hematological, neurological, and other disorder indications after post‑marketing requirements were withdrawn. These withdrawn indications are not reflected in official listings until a Federal Register notice or label update is issued. The...
Dotinurad (FYU-981)
Dotinurad (FYU‑981), marketed as Urece®, is a URAT1 inhibitor approved for gout and hyperuricemia in Japan and China. The drug was chemically refined from the older uricosuric benzbromarone to retain potency while eliminating rare hepatotoxic events. Crystalys Therapeutics is now...
Ongoing | Non-Malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
The FDA’s ongoing accelerated‑approval list details 30+ drugs for non‑malignant hematologic, neurologic and other rare disorders that remain contingent on post‑marketing requirements (PMRs). Each entry cites the indication, approval date, specific confirmatory trial design, and a projected completion date ranging...
Accelerated Approval Program
The FDA’s Accelerated Approval Program permits earlier market entry for drugs treating serious conditions by relying on surrogate endpoints that predict clinical benefit. Companies must later complete confirmatory trials; positive results convert the approval to traditional status, while negative outcomes...
Drive Strategic Growth with Smarter Workforce Planning
U.S. hospitals are pairing enterprise resource planning (ERP) systems with AI‑powered human capital management (HCM) platforms to tighten workforce planning as clinical services expand. Leaders at Johns Hopkins, Henry Ford and Rush describe multi‑year integrations that promise real‑time staffing visibility,...
Psychedelic Stocks Overhyped as Nominee Warns Caution
Psychedelic tape still trades on vibes > policy. Surgeon General nominee Casey Means says she “would not recommend” psilocybin to the American people today. Yes, she nods to “exciting work” in PTSD and veterans. But that is a far cry from...
GLP‑1 Drugs Plus Healthy Habits Cut Heart Events
The combination of GLP-1 drugs (such as Ozempic) and healthy lifestyle factors was associated with less major adverse cardiovascular events in ~100,000 people with T2D @TheLancetEndo https://t.co/phNzEBy7zY https://t.co/DDVi8uedRP
A Review of Efforts to Develop Stem Cell Therapies for Neurodegenerative Conditions
Stem cell therapies for neurodegenerative diseases span unregulated, low‑evidence clinics to proprietary, patent‑protected programs seeking regulatory approval. A new narrative review compiles trial outcomes, highlighting modest benefits—primarily brief inflammation reduction—and significant variability across patients and cell batches. The paper also...
Linking Glucose Control to Vascular Health: Diabetes' Next Frontier
From glucose to vascular health: the future of diabetes care https://t.co/UMhK4BkOE3 #Conditions #Diabetes via @kevinmd
Clinical AI's Future Hinges on Knowledge Integrity Over Architecture
AI isn’t just exposing workflow gaps in healthcare — it’s exposing content fragmentation. The future of clinical AI may depend less on model architecture and more on knowledge integrity. More from @ElsevierConnect at #ViVE2026.👇👇 https://t.co/zbay0c1z1x
FDA Shares New Warning About Johnson & Johnson Heart Pumps After 4 Injuries
The FDA issued an early‑alert notice on February 3, 2026, highlighting a leak risk in Generation 1 purge cassettes used with Johnson & Johnson MedTech’s Impella RP heart‑pump sets. A leak can trigger a low‑pressure alarm, potentially causing biomaterial ingress, pump stoppage, and loss...
AI Expands Beyond Scribes to Entire Healthcare Practice
The future isn’t just AI scribes — it’s AI across the whole practice. Front desk to billing. Hear Venky Chellappa share @charmhealth's approach at #ViVE2026 👇 https://t.co/Fu8iReWUAZ
Regulatory Pressure Forces Hospitals Back to Fax
When government requirements increase data sharing but systems aren’t connected, the fax machine fills the gap. Jess Czelusniak shares what that reality looked like at VHC Health.👇 Hear more about their experience: https://t.co/D7oXKCb2Kg @VyneMedical @VHCHealth #eFax #HITSM https://t.co/mvrhQyx04R
Rare Disease Day Insight: Epilepsy Care Gaps in Pregnancy with UCB’s Andrea Wilkinson — Episode 244
The Xtalks Life Science Podcast’s Episode 244 spotlights a persistent gap in epilepsy care for pregnant women, noting that fewer than 5% of clinical trials include this population. Andrea Wilkinson, UCB’s Global Head of Patient Engagement & Advocacy, discusses new...
Baba Emerges From Stealth with $6.5M to Launch Medicare Advocacy Platform
Baba, a patient‑advocacy startup for seniors, announced its emergence from stealth with a $6.5 million seed round led by General Catalyst. The platform blends dedicated nurses and social‑workers with an AI companion to resolve insurance denials, scheduling gaps, and other operational...